Trogenix
- Biotech or pharma, therapeutic R&D
Trogenix is a cancer gene therapy company with potential for curative responses in solid tumours leveraging our proprietary Synthetic Super Enhancers (SSEs), gene switches that precisely deliver payloads only in target cancer cells. The approach redefines the therapeutic paradigm; strong expression of combination payloads maximizes efficacy, while exquisite selectivity ensures safety.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}